Sfe Investment Counsel Omnicell, Inc Transaction History

Sfe Investment Counsel

$462 Million
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	BUY	$44.6 - $73.38 $26,269 - $43,220	589 Added 5.28%	11,745 $528,000
Q2 2023 Jul 24, 2023	BUY	$57.88 - $75.94 $146,725 - $192,507	2,535 Added 29.4%	11,156 $821,000
Q1 2023 May 08, 2023	SELL	$51.51 - $60.43 $7,984 - $9,366	-155 Reduced 1.77%	8,621 $505,000
Q4 2022 Feb 09, 2023	SELL	$46.24 - $90.03 $146,072 - $284,404	-3,159 Reduced 26.47%	8,776 $442,000
Q3 2022 Nov 14, 2022	BUY	$84.23 - $117.38 $32,428 - $45,191	385 Added 3.33%	11,935 $1.04 Million
Q2 2022 Aug 10, 2022	BUY	$105.64 - $129.11 $193,321 - $236,271	1,830 Added 18.83%	11,550 $1.31 Million
Q1 2022 May 06, 2022	SELL	$120.68 - $180.51 $21,481 - $32,130	-178 Reduced 1.8%	9,720 $1.26 Million
Q4 2021 Feb 07, 2022	SELL	$153.26 - $183.62 $22,682 - $27,175	-148 Reduced 1.47%	9,898 $1.79 Million
Q3 2021 Nov 12, 2021	SELL	$141.84 - $160.88 $137,584 - $156,053	-970 Reduced 8.81%	10,046 $1.49 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $151.45 $62,486 - $72,847	-481 Reduced 4.18%	11,016 $1.67 Million
Q1 2021 Apr 30, 2021	SELL	$117.78 - $143.9 $80,797 - $98,715	-686 Reduced 5.63%	11,497 $1.49 Million
Q4 2020 Feb 04, 2021	SELL	$73.85 - $120.02 $109,297 - $177,629	-1,480 Reduced 10.83%	12,183 $1.46 Million
Q3 2020 Nov 09, 2020	SELL	$63.15 - $77.12 $40,416 - $49,356	-640 Reduced 4.47%	13,663 $1.02 Million
Q2 2020 Aug 05, 2020	BUY	$59.36 - $74.43 $4,748 - $5,954	80 Added 0.56%	14,303 $1.01 Million
Q1 2020 May 04, 2020	BUY	$55.41 - $90.19 $30,475 - $49,604	550 Added 4.02%	14,223 $933,000
Q4 2019 Jan 17, 2020	BUY	$70.15 - $83.11 $180,987 - $214,423	2,580 Added 23.26%	13,673 $1.12 Million
Q3 2019 Oct 31, 2019	BUY	$68.36 - $88.34 $158,937 - $205,390	2,325 Added 26.52%	11,093 $802,000
Q2 2019 Jul 26, 2019	BUY	$71.38 - $92.21 $340,125 - $439,380	4,765 Added 119.04%	8,768 $754,000
Q1 2019 May 08, 2019	SELL	$58.88 - $86.19 $253,242 - $370,703	-4,301 Reduced 51.79%	4,003 $324,000
Q4 2018 Feb 07, 2019	SELL	$56.97 - $77.23 $101,862 - $138,087	-1,788 Reduced 17.72%	8,304 $509,000
Q3 2018 Oct 31, 2018	BUY	$52.65 - $71.9 $18,374 - $25,093	349 Added 3.58%	10,092 $726,000
Q2 2018 Jul 30, 2018	BUY	$42.2 - $53.05 $104,276 - $131,086	2,471 Added 33.98%	9,743 $511,000
Q1 2018 May 01, 2018	SELL	$40.1 - $52.45 $298,745 - $390,752	-7,450 Reduced 50.6%	7,272 $316,000
Q4 2017 Feb 06, 2018	SELL	$45.3 - $54.5 $21,381 - $25,724	-472 Reduced 3.11%	14,722 $714,000
Q3 2017 Nov 01, 2017	BUY	$48.1 - $52.15 $730,831 - $792,367	15,194	15,194 $776,000

Others Institutions Holding OMCL

# of Institutions

274

Shares Held

44.3M

Call Options Held

224K

Put Options Held

35.7K

Black Rock Inc. New York, NY

8.18M
Shares

$346 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.53M
Shares

$234 Million
0.0% of portfolio
State Street Corp Boston, MA

2.27M
Shares

$95.9 Million
0.0% of portfolio
Champlain Investment Partners, LLC Burlington, VT

1.55M
Shares

$65.4 Million
0.43% of portfolio
Dimensional Fund Advisors LP Austin, TX

1.25M
Shares

$52.8 Million
0.01% of portfolio

View Full List

About OMNICELL, Inc

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.87B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

More about OMCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfe Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Sfe Investment Counsel with notifications on news.

Account